Related Experiment Videos
The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases
Jon A Friesen1, Victor W Rodwell
1Department of Chemistry, Illinois State University, Normal, IL 61790-4160, USA. jfriese@ilstu.edu
Genome Biology
|November 13, 2004
Summary
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase is crucial for cholesterol synthesis. Its structure and mechanism are key to understanding how statins work to lower cholesterol levels.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase catalyzes the rate-limiting step in cholesterol and isoprenoid synthesis.
- The enzyme exists in two classes (Class I and Class II) found in eukaryotes and prokaryotes.
- Eukaryotic HMG-CoA reductase is membrane-bound, while prokaryotic forms are soluble.
Purpose of the Study:
- To elucidate the catalytic mechanism of HMG-CoA reductase.
- To understand the structural basis for enzyme activity.
- To provide insights into the action of statin drugs.
Main Methods:
- Phylogenetic analysis to classify HMG-CoA reductases.
- Determination of three-dimensional structures of the catalytic domain.
- Site-directed mutagenesis studies to probe the catalytic mechanism.
Main Results:
- Detailed understanding of the four-electron oxidoreduction mechanism.
- Structural insights into human and bacterial HMG-CoA reductase catalytic domains.
- Identification of HMG-CoA reductase as a target for cholesterol-lowering drugs (statins).
Conclusions:
- HMG-CoA reductase structure and mechanism are conserved across different classes.
- Understanding the enzyme's function is critical for developing hypercholesterolemic therapies.
- Mammalian HMG-CoA reductase regulation is complex, involving multiple levels of control.